Psychedelics

Latest News

Here are highlights from the week in Psychiatric Times.
The Week in Review: June 17-21

June 22nd 2024

Here are highlights from the week in Psychiatric Times.

The outcomes of this study are expected to inform the development of the upcoming PATHFINDER-52 phase 2b clinical trial.
Apex Labs Files IND Application for APEX-52 Study of Take-Home Microdose Psilocybin

June 20th 2024

Here are highlights from the week in Psychiatric Times.
The Week in Review: June 10-14

June 15th 2024

MDMA
Lykos Therapeutics Releases Statement on FDA Advisory Committee Meeting

June 13th 2024

The Psychiatric Times Editor-in-Chief discusses the clinical uses and casual prescribing of ketamine for the treatment of psychiatric disorders.
A Curious Juxtaposition

June 10th 2024

Video Interviews
Podcasts
Latest CME Events & Activities

Advances In™ Schizophrenia: Expanding the Therapeutic Landscape

View More

Expert Illustrations & Commentaries™: Visualizing New Therapeutic Targets in Schizophrenia

View More

Southern California Psychiatry Conference

September 13-14, 2024

Register Now!

Updates on New and Emerging Therapies to Improve Outcomes for Patients With Major Depressive Disorder

View More

PER® Psychiatry Summit

November 7, 2024

View More

2023 Annual Psychiatric Times™ World CME Conference

View More

5th Annual International Congress on the Future of Neurology®

View More

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

View More

Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments

View More

Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies

View More

'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care

View More

Real Psychiatry 2025

January 17 - 18, 2025

View More

More Than ‘Blue’ After Birth: Managing Diagnosis and Treatment of Post-Partum Depression

View More

Patient, Provider & Caregiver Connection™: Reducing the Burden of Parkinson Disease Psychosis with Personalized Management Plans

View More

Expert Perspectives in the Recognition and Management of Postpartum Depression

View More

More News

© 2024 MJH Life Sciences

All rights reserved.